Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31212Not yet recruiting
Open-label, single-arm trial of levothyroxine sodium, sponsored by Slotervaartziekenhuis. Primary endpoints: Prothrombin fragment 1+2, Von Willebrand factor antigen and 7 more. Planned start Jul 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31212.